Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2

Essential oils (Eos) have demonstrated antiviral activity, but their toxicity can hinder their use as therapeutic agents. Recently, some essential oil components have been used within safe levels of acceptable daily intake limits without causing toxicity. The “ImmunoDefender,” a novel antiviral comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ksouri, Ayoub, Klouz, Anis, Bouhaouala-Zahar, Balkiss, Moussa, Fathi, Bezzarga, Mounir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254185/
https://www.ncbi.nlm.nih.gov/pubmed/37298772
http://dx.doi.org/10.3390/molecules28114296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254185/
https://www.ncbi.nlm.nih.gov/pubmed/37298772
http://dx.doi.org/10.3390/molecules28114296

Ejemplares similares